Autoimmune Disease

The diagnosis and treatment of specific autoimmune diseases are described elsewhere in this book. Autoantibodies associated with certain autoimmune diseases may not be pathogenetic but are thought to be markers or by-products of the injury (eg, autoimmune thyroiditis and antithyroglobulin antibody). See Table 19-2 for autoantibody patterns in connective tissue diseases.


Agglutination Assays

Red cells are incubated with purified specific antigen (eg, thyroglobulin), which is adsorbed to the cell surface. The antigen-coated cells are suspended in the patient’s serum, and antibody is detected by red cell agglutination. Antigen-coated latex particles are substituted for red cells in latex fixation tests.

Enzyme-Linked Immunosorbent Assays (ELISA)
Antibodies to various tissue antigens can be readily detected by these tests. Extracted and purified antigens are fixed to a plastic microtiter well or beads. The patient’s serum is added, and excess proteins are removed by washing and centrifugation. Adherent immunoglobulin is then detected when a second antibody coupled to an enzyme (eg, alkaline phosphatase) is added. Finally, the enzyme’s substrate is added; color forms and is measured in a spectrophotometer. This test can also be adapted for antigen detection by placing the antibody on the plastic surface. ELISA assays are very sensitive and less cumbersome than radioimmunoassay techniques.

Immunofluorescence Microscopy
This technique is most frequently used for detection of antinuclear antibody (ANA). Frozen sections of mouse liver or other substrates are cut and placed on glass slides or, alternatively, monolayers of cultured cell lines may be used. A patient’s serum is placed over the sections and incubated. Fluorescein-conjugated rabbit anti-human immunoglobulin is then applied and washed. Antinuclear antibody specifically binds to the nucleus, and the fluorescein conjugate binds to the human antibody. Fluorescence of the cell nucleus on microscopy indicates a positive test.

Complement Fixation
Specific antigen, unknown serum, and complement are combined. Sheep red blood cells coated with anti-sheep cell antibody are added for 30 minutes at 37 °C. If antigen-specific antibody is present in the patient’s serum, complement is bound and consumed, preventing lysis of sheep red cells.

Arbuckle MR: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526.

D’Cruz D: Testing for autoimmunity in humans. Toxicol Lett 2002;127:93.

Egner W: The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000;53:424.

Newkirk MM: Rheumatoid factors: host resistance or autoimmunity? Clin Immunol 2002;104:1.

Provided by ArmMed Media
Revision date: June 14, 2011
Last revised: by Dave R. Roger, M.D.